Intended for healthcare professionals


Four in five asthma deaths may be due to long acting β agonists

BMJ 2006; 332 doi: (Published 22 June 2006) Cite this as: BMJ 2006;332:1467
  1. Pat Hagan
  1. London

    Eighty per cent of deaths related to asthma in the United States may be due to the use of long acting β agonists, indicate the results of a meta-analysis of 19 clinical trials.

    The results of the review, published in the Annals of Internal Medicine (2006;144; 901-12), have led to calls for the drugs to be withdrawn from the US market.

    “We can show that overall it is statistically significant that, compared with patients taking a placebo, these long acting β agonists kill a lot …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription